EBUS-TBNA vs EUS-B-FNA for Needle Aspiration of Mediastinal Lesions
Launched by ALL INDIA INSTITUTE OF MEDICAL SCIENCES · Mar 8, 2016
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Objectives
Primary objective:
Comparison of Proportion of Adequate and Diagnostic Aspirates in the EUS-B-FNA versus EBUS-TBNA arms as the primary approach for mediastinal fine needle aspiration during Convex probe EBUS.
Secondary objectives
1. Topical Anaesthetic requirement between the two groups
2. Intravenous Sedative / analgesic requirement between the two groups
3. Operator rated overall procedure satisfaction (VAS)
4. Operator rated cough (VAS)
5. Overall duration of procedure Methods Study Design: Prospective randomised study. Sample Size: Number of Patients: 100 (50 -EBUS-TBNA a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years and Older
- • Predominant Subcarinal or Lower Left paratracheal located mediastinal lymphadenopathy/mediastinal lesions at least \>1cm in Short axis diameter.
- • Patients who give consent
- Exclusion Criteria:
- • Refusal of consent for the procedure
- • Any contraindications to Bronchoscopy / Endobronchial Ultrasound
- • Pregnancy
About All India Institute Of Medical Sciences
The All India Institute of Medical Sciences (AIIMS) is a premier medical institution and research center in India, recognized for its commitment to advancing healthcare through innovative research and clinical trials. Established with the mission to provide high-quality medical education, patient care, and groundbreaking research, AIIMS plays a pivotal role in the development and evaluation of new therapies and interventions. Its multidisciplinary approach, combined with a robust infrastructure and a team of leading healthcare professionals, positions AIIMS as a key player in the global clinical research landscape, dedicated to improving health outcomes and fostering scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, , India
Patients applied
Trial Officials
Randeep Guleria
Study Chair
All India Institute of Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials